In the wire
Nokia Corporation - Managers' transactions (Hanrahan)
Nokia Corporation Managers’ transactions 14 August 2026 at 15:30 EEST Nokia Corporation - Managers' transactions (Hanrahan)
Aug 14 · 12:30GlobeNewswire
Nokia Corporation Managers’ transactions 14 August 2026 at 15:30 EEST Nokia Corporation - Managers' transactions (Hanrahan)
Nokia Corporation Managers’ transactions 14 August 2026 at 15:30 EEST Nokia Corporation - Managers' transactions (Prosi)
Nokia Oyj Johtohenkilöiden liiketoimet 14.8.2026 klo 15.30 Nokia Oyj - Johtohenkilöiden liiketoimet (Fisk)
Nokia Oyj Johtohenkilöiden liiketoimet 14.8.2026 klo 15.30 Nokia Oyj - Johtohenkilöiden liiketoimet (Hanrahan)
Nokia Oyj Johtohenkilöiden liiketoimet 14.8.2026 klo 15.30 Nokia Oyj - Johtohenkilöiden liiketoimet (Prosi)
MARKHAM, Ontario, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “ Common Share ”) for the month of August 2026, representing $0.936 per Common Share on an annualized basis.
BLUE BELL, Pa., Aug. 14, 2026 /PRNewswire/ -- Unisys (NYSE: UIS) has announced that members of its management team will host one-on-one and small group meetings at the following upcoming investor conferences: Midwest IDEAS Conference, Aug. 27, 2026, in Chicago, Ill. Sidoti Small-Cap...
The global Smart Greenhouse Market size was valued at USD 5.8 billion in 2025 and is projected to grow from USD 6.6 billion in 2026 to USD 18.0 billion by [read full press release...]
(PR-inside.com) Mipletamig Drives Clinical Momentum with Strong Frontline AML Data, Path Toward Phase 2 Chief Scientific Officer Appointment Strengthens Execution Across Advancing Oncology Pipeline Non-Dilutive Grant Funding Advances APVO451 and Validates Trispecific Solid Tumor Strategy Strategic Niowave Collaboration Opens a New Radiopharmaceutical Therapeutic Development Opportunity SEATTLE, WA / ACCESS Newswire / August 14, 2026 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company developing novel immuno-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, today reported financial results for the quarter ended June 30, 2026 and provided a business update highlighting strong clinical progress for mipletamig, strengt
Mipletamig Drives Clinical Momentum with Strong Frontline AML Data, Path Toward Phase 2 Chief Scientific Officer Appointment Strengthens Execution Across Advancing Oncology Pipeline Non-Dilutive Grant Funding Advances APVO451 and Validates Trispecific Solid Tumor Strategy Strategic Niowave Collaboration Opens a New Radiopharmaceutical Therapeutic Development Opportunity
- New framework supports production of critical Standard Missile-3 parts to help intercept threats outside Earth’s atmosphere
(PR-inside.com) NEW YORK, NY / ACCESS Newswire / August 14, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Hertz Global Holding, Inc. (NASDAQ:HTZ) securities. If you suffered a loss on your Hertz Global Holding, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Hertz Global Holding, Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit ..